Literature DB >> 7485311

Fetal liver cell transplantation for the creation of lymphohematopoietic chimerism in fetal baboons.

L E Shields1, E M Bryant, T R Easterling, R G Andrews.   

Abstract

OBJECTIVE: Our purpose was to create xenogeneic lymphohematopoietic chimerism by in utero transplantation of human fetal liver cells in the midgestation fetal baboon. STUDY
DESIGN: Human fetal liver cell suspensions obtained from preimmune human fetuses (< 80 days' gestation) were injected into the peritoneal cavity of three fetal baboons (85, 95, and 104 days' gestation). A total of 9 x 10(6) cells, in a volume of 1 ml, were injected percutaneously into the fetal abdominal cavity under ultrasonographic guidance. The success of the injection was assessed by observing ascites and free loops of fetal bowel after injection. Fetal umbilical cord blood (35 days posttransplantation) and neonatal blood and bone marrow were obtained to be assayed for the presence of donor hematopoietic cells. Chimerism was detected by fluorescence in situ hybridization with a human Y-chromosome specific probe.
RESULTS: All the animals survived the in utero procedures. Thirty-five days after transplantation engraftment was noted in one animal. Postnatally the same animal showed engraftment in both the peripheral blood and bone marrow. The rate of chimerism was 1.5% (1.5% of the cells were human) in both the peripheral blood and bone marrow.
CONCLUSIONS: This study demonstrates that creation of xenogeneic lymphohematopoietic chimerism is possible in the midgestation fetal baboon. However, the level of chimerism was too low to study the biologic activity of the transplanted cells or to potentially ameliorate lymphohematopoietic disorders. Future studies using allogeneic tissue, evaluating cells obtained from both fetal and adult donors, and comparisons between purified stem cells and fetal liver cells are needed.

Entities:  

Mesh:

Year:  1995        PMID: 7485311     DOI: 10.1016/0002-9378(95)91344-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.

Authors:  William H Peranteau; Masayuki Endo; Obinna O Adibe; Aziz Merchant; Philip W Zoltick; Alan W Flake
Journal:  Blood       Date:  2006-09-05       Impact factor: 22.113

2.  EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool.

Authors:  Evan Colletti; Deena El Shabrawy; Melisa Soland; Takashi Yamagami; Saloomeh Mokhtari; Craig Osborne; Karen Schlauch; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  FASEB J       Date:  2013-02-14       Impact factor: 5.191

3.  Temporal definition of haematopoietic stem cell niches in a large animal model of in utero stem cell transplantation.

Authors:  Christine Jeanblanc; Angelina Daisy Goodrich; Evan Colletti; Saloomeh Mokhtari; Christopher D Porada; Esmail D Zanjani; Graça Almeida-Porada
Journal:  Br J Haematol       Date:  2014-03-27       Impact factor: 6.998

4.  Pre-Existing Maternal Antibodies Cause Rapid Prenatal Rejection of Allotransplants in the Mouse Model of In Utero Hematopoietic Cell Transplantation.

Authors:  John S Riley; Lauren E McClain; John D Stratigis; Barbara E Coons; Haiying Li; Heather A Hartman; William H Peranteau
Journal:  J Immunol       Date:  2018-07-18       Impact factor: 5.422

5.  Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.

Authors:  William H Peranteau; Satoshi Hayashi; Osheiza Abdulmalik; Qiukan Chen; Aziz Merchant; Toshio Asakura; Alan W Flake
Journal:  Blood       Date:  2015-06-29       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.